Pharmaceutical Research and Manufacturers of America
501(c)(6)
Pharmaceutical Research and Manufacturers of America is a 501(c)(6) organization based in Washington, District of Columbia, registered in 1959, with $521,348,217 in FY2024 revenue.
670 Maine Avenue Sw 1000, Washington, DC, 20024 EIN 53-0241211 Since 1959
Revenue (FY2024)
$521.3M
▲ 7.9% vs prior year
Expenses (FY2024)
$578.3M
Net assets
$158.5M
Employees
300
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
B+
—Program efficiency40% of the ratingNo expense breakdown in filings
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Pharmaceutical Research and Manufacturers of America— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
C+Financial health25% of the rating3 mo reserves · -11% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Pharmaceutical Research and Manufacturers of America: 3 mo reserves · -11% margin earns a C+ on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Pharmaceutical Research and Manufacturers of America: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Pharmaceutical Research and Manufacturers of America: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
Phrma's mission is to conduct effective advocacy for public policies that encourage the discovery of important new medicines for patients by biopharmaceutical research companies.
What they do
Member services: in representing the country's leading pharmaceutical research and biotechnology companies, phrma provides a forum for member companies to participate in discussions of relevant health care issues and to develop consensus positions on matters of public policy advocacy. member companies participate in phrma activities through representation on the board of directors, board-level committees, staff work groups, sections, and task forces. member company representatives also regularly communicate with phrma staff.
General education about biopharmaceutical industry: phrma disseminates information about biopharmaceutical companies, their products, and their business, scientific and philanthropic activities through a wide range of channels, including profiles, reports, principles, guidelines, fact sheets, policy papers and other resources. these efforts bolster phrma's ability to educate and inform members of the general public as well as policymakers, the media, patients and others in the health care community about the biopharmaceutical industry and phrma's public policy activities in particular.
Contact & location
- Address
- 670 Maine Avenue Sw 1000, Washington, DC, 20024
- City
- Washington
- State
- District of Columbia
- Category
- —
- Subcategory
- —
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $204.7M (FY2013) to $521.3M (FY2024) across 12 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $190.5MNet assets $158.5M
Operating margin
-10.9%
Spent more than it raised in the latest fiscal year.
Total assets
$349.0M
Total liabilities
$190.5M
Net assets
$158.5M
Salaries & benefits
$113.0M
20% of expenses
Board members
32
31 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $521,348,217▲7.9% | $578,265,057▲35.6% | $158,537,255▼24.8% | $349,012,370▼12.5% | 990 |
| 2023 | $483,040,082▼15.0% | $426,549,040▼25.7% | $210,928,967▲39.1% | $398,950,677▲39.4% | 990 |
| 2022 | $568,384,699▼6.7% | $574,376,853▼2.5% | $151,666,708▲29.7% | $286,234,000▲0.5% | 990 |
| 2021 | $609,259,357▲6.2% | $588,810,520▲7.0% | $116,901,726▲25.2% | $284,877,801▲33.7% | 990 |
| 2020 | $573,617,938▲8.9% | $550,191,718▲8.8% | $93,383,579▲20.5% | $213,146,031▲10.5% | 990 |
| 2019 | $526,601,050▲14.7% | $505,590,709▲12.9% | $77,486,565▲78.3% | $192,855,755▲3.2% | 990 |
| 2018 | $459,096,153▲0.7% | $447,626,111▼3.4% | $43,457,518▲89.0% | $186,814,044▲10.4% | 990 |
| 2017 | $455,738,725▲68.4% | $463,576,374▲65.3% | $22,991,641▼39.4% | $169,181,567▼3.9% | 990 |
| 2016 | $270,606,605▲22.9% | $280,442,377▲24.7% | $37,944,123▼24.8% | $176,069,125▲2.8% | 990 |
| 2015 | $220,251,342▲5.6% | $224,949,269▲8.2% | $50,484,631▲19.2% | $171,355,423▲26.4% | 990 |
| 2014 | $208,652,106▲1.9% | $207,941,637▲2.9% | $42,351,339▼49.4% | $135,545,781▲4.1% | 990 |
| 2013 | $204,711,986 | $202,129,760▼1.9% | $83,731,994▲68.1% | $130,160,555▲1.9% | 990 |
| 2012 | — | $206,117,606▲2.5% | $49,803,236▼5.4% | $127,678,178▼0.8% | 990 |
| 2011 | — | $201,124,812▼4.8% | $52,633,538▼12.5% | $128,749,479▲8.4% | 990 |
| 2010 | — | $211,265,586 | $60,181,597 | $118,727,204 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: Stephen J Ubl — $5,935,826 (1.03% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Stephen J Ubl | President & Ceo | 37.5 | $5,935,826 |
| Lori Reilly | Coo | 37.5 | $2,547,833 |
| Anne Pritchett | Svp, Policy/research | 37.5 | $2,066,592 |
| Jennifer Bryant | Evp, Policy/research | 37.5 | $1,858,936 |
| James C Stansel | General Counsel & Evp Law, Secretary | 37.5 | $1,761,157 |
| Tracey Merchant | Cfo & Evp, Administration | 37.5 | $1,340,588 |
| Scott Laganga | Evp, State Advocacy | 37.5 | $1,199,864 |
| Robert Zirkelbach II | Evp, Public Affairs | 37.5 | $1,190,211 |
| Michael Woody | Svp, Federal Advocacy | 37.5 | $1,175,941 |
| Shannon Monsif | Evp, Alliance | 37.5 | $1,115,048 |
| Elizabeth Carpenter | Evp, Policy/research | 37.5 | $1,077,102 |
| Jay Taylor | Evp, International | 37.5 | $990,116 |
| Kenneth K Mckay IV | Svp, State Advocacy | 37.5 | $935,523 |
| Steven Tilton | Evp, Federal Advocacy | 37.5 | $920,326 |
| Renuka Iyer | Evp, Human Resources | 37.5 | $652,356 |
| Albert Bourla Phd | Vice Chair | 2 | — |
| Alexander Hardy | Director | 2 | — |
| Anthony Mancini | Director (thru 08/24) | 2 | — |
| Ashley Magargee | Director | 2 | — |
| Barry Greene | Director | 2 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Locust Street Solutions LLC | Advocacy Consulting | $6,947,102 |
| Latham & Watkins LLP | Legal Consulting | $5,734,074 |
| Arnold & Porter Kaye Scholer LLP | Legal Consulting | $4,251,604 |
| Covington & Burling LLP | Legal Consulting | $3,963,100 |
| Purple Strategies LLC | Comms Strategy | $3,714,008 |
Grants received · $86K total
3 grants to Pharmaceutical Research and Manufacturers of America totaling $86K, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Biotechnology Innovation Organization | General support | 2019 | $40,000 |
| Biotechnology Innovation Organization | Sponsorship | 2018 | $40,000 |
| Biotechnology Innovation Organization | General support | 2017 | $5,500 |
Grants made · $41.4M in FY2024
461 grants totaling $41.4M in FY2024 — showing the 15 largest. All grants made by Pharmaceutical Research and Manufacturers of America →
| Recipient | Purpose | Amount |
|---|---|---|
| We Work For Health | General contribution | $6,827,095 |
| Yale University | General contribution | $5,000,000 |
| American Action Network Inc | General contribution | $4,000,000 |
| National Consumers League Inc | General contribution | $875,000 |
| National Alliance of Healthcare Purchaser Coalitions Inc | General contribution | $850,000 |
| Phrma Independent Expenditure Committee | Political contribution | $842,096 |
| The Campaign To Protect Patient Health | General contribution | $660,000 |
| Council For Affordable Health Coverage | General contribution | $615,000 |
| Republican State Leadership Committee | Political contribution | $550,000 |
| Information Technology Andinnovation Foundation | General contribution | $515,000 |
| Republican Governors Association | Political contribution | $500,000 |
| Minnesotans For Freedom | General contribution | $500,000 |
| Pnw Phrma Pac | Political contribution | $417,500 |
| Domestic Policies Caucus | General contribution | $391,000 |
| National Health Council Inc | General contribution | $390,000 |
Frequently asked questions
- Is Pharmaceutical Research and Manufacturers of America a legitimate nonprofit?
- Yes. Pharmaceutical Research and Manufacturers of America is a 501(c)(6) organization registered with the U.S. Internal Revenue Service under EIN 53-0241211, based in Washington, District of Columbia.
- What is Pharmaceutical Research and Manufacturers of America's EIN?
- Pharmaceutical Research and Manufacturers of America's Employer Identification Number (EIN) is 53-0241211.
- How much revenue does Pharmaceutical Research and Manufacturers of America report?
- Pharmaceutical Research and Manufacturers of America reported $521,348,217 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much does Pharmaceutical Research and Manufacturers of America's highest-paid employee make?
- The highest reported compensation on Pharmaceutical Research and Manufacturers of America's latest Form 990 is $5,935,826, paid to Stephen J Ubl (President & Ceo).
More nonprofits in Washington
Explore more
Data for Pharmaceutical Research and Manufacturers of America (EIN 53-0241211) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.